Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib and androgen ablation in locally advanced prostate cancer
NCT01163084Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jul 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in prostate adenocarcinoma, sponsored by National Cancer Institute. Started Jul 2010; status: terminated.
02
Drugs
vismodegib
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT01163084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01163084.